12:33 PM EST - Nirvana Life Sciences Inc : Announces that it has signed a letter of intent with Innovate Phytotechnologies Inc. for the development and distribution of the Company's psilocybin and psilocin based products. The strategic relationship will begin with the production of 20g each of psilocybin and psilocin and will increase with market demands. Nirvana Life Sciences Inc
shares C.NIRV are trading up one cent at $0.48.
